As the world marks the grim milestone of 5 million COVID-19 deaths, health systems and patients are living under the threat of a second COVID-19 related health disaster—an acceleration of illness and mortality born of health care delayed or abandoned over the course of the pandemic. This is particularly acute among those living with cancer. […]
On 19 May EFPIA, the European Federation of Pharmaceutical Industries and Associations, organised “Clinical Trials at the time of COVID-19 – and beyond”, as part of the series of our virtual events. On the occasion of International Clinical Trials Day on 20 May, this event wished to explore the takeaways that COVID-19 teaches us on how to optimise […]
What will the ultimate cost of COVID-19 be? In this insightful piece, Dr Tessa Richards discusses the wide impact on health of the COVID-19 pandemic, from the repercussions that we start to perceive to the potential and hidden figures.
The COVID-19 pandemic has affected every aspect of cancer care, putting cancer patients at higher risk of poor outcomes. The “Every Day Counts – The impact of COVID-19 on patient access to oncology care in Europe” publication aims to provide a comprehensive overview of the significant impact of COVID-19 on cancer patients and their access […]
Myeloma Patients Europe (MPE) has developed a Q&A on COVID-19 vaccination for myeloma patients to answer some of the most frequently asked questions about the approved COVID-19 vaccines in Europe. It is available in German, Armenian, Romanian, Spanish, Macedonian, French, Slovak, Hebrew and Lithuanian. Portuguese, Danish and Finnish coming soon.
Videos and podcasts for health workers and the public to address common questions about COVID-19 vaccines.
This ESMO Webinar Series provides some important considerations about COVID-19 vaccination for patients with cancer.
Experts discuss how to best protect people with diabetes from serious COVID-19 outcomes in a newly published article that summarizes in-depth discussions on the topic from a conference held online last year.
EMA is organized this open event to: explain the basis for the approval and use of the new COVID-19 vaccines and how the safety of the vaccines will be assured; provide information on the roles of the European Commission and national public health authorities in the roll-out of the vaccines; listen to the needs, expectations, and […]
In this episode of a webinar series called Targeted Talks, Debra Patt, MD, PhD, MBA, oncologist, and breast specialist, Texas Oncology, speaks with Alex Spira, MD, PhD, FACP, medical oncologist, Virginia Cancer Specialists, about the impact of the coronavirus disease 2019 (COVID-19) pandemic on community cancer centers and hospitals in the United States. As a […]
